Are SGLT-2 Inhibitors the Future of Heart Failure Treatment? The EMPEROR-Preserved and EMPEROR-Reduced Trials
Crossref DOI link: https://doi.org/10.1007/s13300-020-00889-9
Published Online: 2020-07-24
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Williams, David M. http://orcid.org/0000-0001-9206-5837
Evans, Marc
Text and Data Mining valid from 2020-07-24
Version of Record valid from 2020-07-24
Article History
Received: 7 July 2020
First Online: 24 July 2020